What Is a CGM (Continuous Glucose Monitor) and How Do I Choose One?

DiabetesMine explains the basics of CGM (continuous glucose monitors), how to choose one, costs, insurance coverage, and where to buy.
Source: Diabetes Mine - Category: Endocrinology Authors: Source Type: blogs

Related Links:

Publication date: Available online 18 September 2019Source: Biocatalysis and Agricultural BiotechnologyAuthor(s): Jayanthi Balakrishnan, Senthil Kumar Thamilarasan, Manoj Srinivas Ravi, Arivalagan Pugazhendhi, Venkatachalam Perumal, Indra Arulselvi PadikasanAbstractOur study investigated the nutrient profiles, bioactive metabolites, antioxidant and anti-diabetic properties of traditional rice varieties such as Puzhuthikar (PTS), Elupaipoo Samba (EPS), Valan Samba (VS) and Garudan Samba (GS). The total phenols and flavonoids were significantly higher in PTS followed by GS, EPS and VS. Gas chromatography and Mass spectroscop...
Source: Biocatalysis and Agricultural Biotechnology - Category: Biotechnology Source Type: research
Publication date: Available online 18 September 2019Source: The Journal of Steroid Biochemistry and Molecular BiologyAuthor(s): Rolf Jorde, Tom Wilsgaard, Guri GrimnesAbstractVitamin D deficiency is associated with diabetes, cancer, immunological and cardiovascular diseases as well as increased mortality. It has, however, been difficult to show a causal relation in randomized, controlled trials. Mendelian randomization studies provide another option for testing causality, and results indicate relations between the serum 25-hydroxyvitamin D (25(OH)D) level and some diseases, including mortality. We have from the Troms&oslas...
Source: The Journal of Steroid Biochemistry and Molecular Biology - Category: Biochemistry Source Type: research
ConclusionsContent review highlights the various self-management capabilities offered by diabetes apps. This study adds to the extant literature on mobile application classification by introducing the business model dimension.
Source: Health Policy and Technology - Category: Health Management Source Type: research
Bardoxolone methyl has been considered a potential therapy for several types of kidney disease because it activates a cytoprotective factor and inhibits a proinflammatory factor. In the Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes (BEACON) trial, bardoxolone was tested in patients with diabetic nephropathy and advanced chronic kidney disease (CKD) and was found to improve estimated glomerular filtration rate (eGFR); however, it also increased albuminuria.
Source: Kidney International - Category: Urology & Nephrology Tags: In This Issue Source Type: research
Diabetic kidney disease (DKD) results from a complex interplay between genetics, environment, and behavioral factors. Hyperglycemia-induced metabolic alterations, including changes in energy utilization and mitochondrial dysfunction, play critical roles in disease initiation. Although DKD has long been regarded as a microvascular complication of diabetes, reduced podocyte number was also shown to correlate strongly with albuminuria and loss of glomerular filtration rate (GFR) in Pima Native Americans with type 2 diabetes.
Source: Kidney International - Category: Urology & Nephrology Authors: Tags: Nephrology Digest Source Type: research
Bardoxolone methyl activates nuclear factor erythroid 2-related factor 2 and increases glomerular filtration rate in patients with diabetic kidney disease. Because bardoxolone methyl also increases albuminuria, Rossing and colleagues performed a retrospective analysis of the Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes (BEACON) study and attributed increased albuminuria to increased estimated glomerular filtration rate. Although the study emphasizes bardoxolone methyl ’s benefits in diabetic kidney disease, we must be careful about interpretation.
Source: Kidney International - Category: Urology & Nephrology Authors: Tags: Commentary Source Type: research
In this commentary we emphasize the renoprotective effect of cyclic  angiotensin-(1-7) described by Cassis et al. in a mouse model of diabetic kidney disease. The importance of the study is that this peptide was even more protective than the angiotensin-converting enzyme inhibitor lisinopril administered alone and that when the 2 componds were combined, the ren oprotective action was additive.
Source: Kidney International - Category: Urology & Nephrology Authors: Tags: Commentary Source Type: research
Advances in Research on the Protective Mechanisms of Traditional Chinese Medicine (TCM) in Islet β Cells. Evid Based Complement Alternat Med. 2019;2019:7526098 Authors: Li N, Zhang H, Li X Abstract The dysfunction and decreased number of islet β cells are central to the main pathogenesis of diabetes. Improving islet β cell function and increasing the number of β cells are effective approaches to treat diabetes and constitute the main direction of diabetes drug development. The role of Chinese medicine in the treatment of diabetes began to be recognized. In recent years, Chinese medi...
Source: Evidence-based Complementary and Alternative Medicine - Category: Complementary Medicine Tags: Evid Based Complement Alternat Med Source Type: research
Authors: Mohd Sahardi NFN, Makpol S Abstract Currently, the age of the population is increasing as a result of increased life expectancy. Ageing is defined as the progressive loss of physiological integrity, which can be characterized by functional impairment and high vulnerability to various types of diseases, such as diabetes, hypertension, Alzheimer's disease (AD), Parkinson's disease (PD), and atherosclerosis. Numerous studies have reported that the presence of oxidative stress and inflammation contributes to the development of these diseases. In general, oxidative stress could induce proinflammatory cytokines ...
Source: Evidence-based Complementary and Alternative Medicine - Category: Complementary Medicine Tags: Evid Based Complement Alternat Med Source Type: research
Authors: Ou Y, Zhang C, Yao M, Wang L Abstract Cardiovascular disease (CVD) is one of the three major threats to human health identified by WHO. Dyslipidemia, hypertension, diabetes, and obesity are well established as common CVD risk factors. However, controversies exist on the effects of gut flora on cardiovascular disease (CVD). Current evidence suggests that gut microbiota is a double-edged sword for CVD risk, and its effects are largely determined by the metabolites of the gut microbiota. Trimethylamine N-oxide (TMAO), as one of the metabolites of gut flora, is consistently associated with higher CVD risk. A f...
Source: Evidence-based Complementary and Alternative Medicine - Category: Complementary Medicine Tags: Evid Based Complement Alternat Med Source Type: research
More News: Diabetes | Endocrinology | Insurance